Company Filing History:
2 out of 832,812 Years Active: 2011-2012
Title: Suhas Lele: Innovator in Cardiac Event Prediction and Treatment
Introduction
Suhas Lele is a notable inventor based in Baroda, India. He has made significant contributions to the field of cardiac health through his innovative methods for predicting and treating adverse cardiac events. With a total of 2 patents to his name, Lele's work focuses on early detection and treatment of acute coronary syndrome.
Latest Patents
Lele's latest patents include groundbreaking inventions aimed at improving cardiac care. The first patent, titled "Methods of predicting and treating adverse cardiac events," provides methods for the treatment of acute coronary syndrome. This invention allows for the prediction of adverse cardiac events based on elevations of catalytic iron in biological fluids. It includes a method for early detection of acute coronary syndrome (ACS) at the time of chest pain presentation by analyzing a test sample for catalytic iron levels.
The second patent, "Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events," also focuses on early diagnosis of ACS. Similar to the first, it utilizes the analysis of catalytic iron in biological fluids to predict adverse cardiac events. This method enhances the ability to detect ACS in patients promptly.
Career Highlights
Throughout his career, Suhas Lele has worked in various capacities that have allowed him to develop his innovative ideas. His experience in the medical field has been instrumental in shaping his inventions.
Collaborations
Lele has collaborated with notable individuals such as Mohan Rajapurkar and Sudhir V Shah. These collaborations have contributed to the development and refinement of his patented methods.
Conclusion
Suhas Lele's contributions to cardiac health through his innovative patents demonstrate his commitment to improving patient outcomes. His work in early detection and treatment of acute coronary syndrome is a testament to his expertise and dedication to medical innovation.